The ChIP assay further revealed tentative YAP/TEAD1‐binding sites and validated the enhanced bindings of YAP in promoter regions of antioxidant genes in HFD tumor cells than in LFD cells (Figure 4F). Here, TEAD1 is linked to neoplasm.